• Breast tumours (5th ed.) 
• 1. Forewords and Introductions
  
  
  
  
  WHO Classification of Tumours: Editorial Board
  How to cite this volume
  Foreword with changes from the book, including corrigenda
  ICD-O coding of breast tumours
  TNM staging of carcinomas of the breast
  ICCR datasets: Breast
  Introduction to tumours of the breast
  
  
  
  
• 2. Epithelial tumours of the breast
  
  
  
  
  Benign epithelial proliferations and precursors: Introduction
  Usual ductal hyperplasia
  Columnar cell lesions, including flat epithelial atypia
  Atypical ductal hyperplasia
  Adenosis and benign sclerosing lesions: Introduction
  Sclerosing adenosis
  Apocrine adenosis and adenoma
  Microglandular adenosis
  Radial scar / complex sclerosing lesion
  Adenomas: Introduction
  Tubular adenoma
  Lactating adenoma
  Ductal adenoma
  Epithelial-myoepithelial tumours: Introduction
  Pleomorphic adenoma
  Adenomyoepithelioma
  Malignant adenomyoepithelioma
  Papillary neoplasms: Introduction
  Intraductal papilloma
  Papillary ductal carcinoma in situ
  Encapsulated papillary carcinoma
  Solid papillary carcinoma (in situ and invasive)
  Invasive papillary carcinoma
  Non-invasive lobular neoplasia: Introduction
  Atypical lobular hyperplasia
  Lobular carcinoma in situ
  Ductal carcinoma in situ: Introduction
  Ductal carcinoma in situ
  Invasive breast carcinoma: General overview
  Invasive breast carcinoma of no special type
  Microinvasive carcinoma
  Invasive lobular carcinoma
  Tubular carcinoma
  Cribriform carcinoma
  Mucinous carcinoma
  Mucinous cystadenocarcinoma
  Invasive micropapillary carcinoma
  Carcinoma with apocrine differentiation
  Metaplastic carcinoma
  Rare and salivary gland-type tumours: Introduction
  Acinic cell carcinoma
  Adenoid cystic carcinoma
  Secretory carcinoma
  Mucoepidermoid carcinoma
  Polymorphous adenocarcinoma
  Tall cell carcinoma with reversed polarity
  Neuroendocrine neoplasms: Introduction
  Neuroendocrine tumour
  Neuroendocrine carcinoma
  
  
  
  
• 3. Fibroepithelial tumours and hamartomas of the breast
  
  
  
  
  Fibroepithelial tumours and hamartomas of the breast: Introduction
  Hamartoma
  Fibroadenoma
  Phyllodes tumour
  
  
  
  
• 4. Tumours of the nipple
  
  
  
  
  Tumours of the nipple: Introduction
  Epithelial tumours
  Syringomatous tumour
  Nipple adenoma
  Paget disease of the breast
  
  
  
  
• 5. Mesenchymal tumours of the breast
  
  
  
  
  Mesenchymal tumours of the breast: Introduction
  Vascular tumours
  Haemangioma
  Angiomatosis
  Atypical vascular lesions
  Postradiation angiosarcoma of the breast
  Primary angiosarcoma of the breast
  Fibroblastic and myofibroblastic tumours
  Nodular fasciitis
  Myofibroblastoma
  Desmoid fibromatosis
  Inflammatory myofibroblastic tumour
  Peripheral nerve sheath tumours
  Schwannoma
  Neurofibroma
  Granular cell tumour
  Smooth muscle tumours
  Leiomyoma
  Leiomyosarcoma
  Adipocytic tumours
  Lipoma
  Angiolipoma
  Liposarcoma
  Other mesenchymal tumours and tumour-like conditions
  Pseudoangiomatous stromal hyperplasia
  
  
  
  
• 6. Haematolymphoid tumours of the breast
  
  
  
  
  Haematolymphoid tumours of the breast: Introduction
  Lymphoma
  Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)
  Follicular lymphoma
  Diffuse large B-cell lymphoma
  Burkitt lymphoma
  Breast implant-associated anaplastic large cell lymphoma
  
  
  
  
• 7. Tumours of the male breast
  
  
  
  
  Tumours of the male breast: Introduction
  Epithelial tumours
  Gynaecomastia
  Carcinoma in situ
  Invasive carcinoma
  Metastases to the breast
  
  
  
  
• 8. Genetic tumour syndromes of the breast
  
  
  
  
  Genetic tumour syndromes of the breast: Introduction
  Syndromes
  BRCA1/2-associated hereditary breast and ovarian cancer syndrome
  Cowden syndrome
  Ataxia-telangiectasia
  Li-Fraumeni syndrome, TP53-associated
  Li-Fraumeni syndrome, CHEK2-associated
  CDH1-associated breast cancer
  PALB2-associated cancers
  Peutz-Jeghers syndrome
  Neurofibromatosis type 1
  The polygenic component of breast cancer susceptibility